Zachary Javitt

Zachary Javitt has held various roles in different companies throughout their work experience. Starting in 2006, they worked as a Summer Fellow at the NICHD, researching the effects of 7-Keto-Cholesterol metabolism. In 2008, they continued their work at the NICHD as a Summer Fellow, this time researching the effects of Smith-Lemli-Opitz Syndrome and compiling a global database of variances. In 2009, Javitt served as a Sales representative at Bethesda Tobacco Inc., where they achieved steady growth despite a decline in the luxury market. From 2011 to 2013, they interned at the Hudson Institute. In 2013, they joined Knot Standard and served as the Program Director for the Military Suiting Program, and later as a Sales and Operation Executive. In 2015, Javitt became the Director of Brand Strategy at NRx Pharmaceuticals, Inc., contributing to the development of a combination therapy targeting bipolar depression. Also in 2015, they co-founded PillTracker Ltd. and currently serves as the CEO. Overall, Javitt has a diverse background in research, sales, operations, and executive roles across multiple industries.

Zachary Javitt obtained a BA in Economics from Columbia University in the years 2010 to 2015. Additionally, they earned a second BA in Bible/Biblical Studies from The Jewish Theological Seminary (JTS) during the same time period.